Table 1.
Demographic and clinical data of patients
| Children with and without MetS (n = 60) | Children without MetS (normal level) (n = 42) | Children with MetS (monitoring/action level) (n = 18) | p-valuea | |
|---|---|---|---|---|
| Male, n (%) | 30 (50) | 23 (55) | 7 (39) | 0.06 |
| Female, n (%) | 30 (50) | 19 (45) | 11 (61) | 0.08 |
|
Age, years, mean ± SD Median ± IQR |
7.8 ± 2.4 9.0 ± 4.0 |
7.8 ± 2.4 9.0 ± 4.0 |
7.71 ± 2.4 8.5 ± 3.0 |
0.85 |
| Weight, kg, mean ± SD | 35.2 ± 14.1 | 35.2 ± 14.1 | 34.9 ± 14.1 | 0.004 |
| Height, cm, mean ± SD | 133 ± 16.9 | 133.36 ± 16.9 | 140.1 ± 13.6 | 0.22 |
|
BMI, mean ± SD Median ± IQR |
19.0 ± 4.3 17.6 ± 6.7 |
19.0 ± 4.3 16.6 ± 4.8 |
18.8 ± 4.7 21.8 ± 4.9 |
0.001 |
| Normal weight, n (%) | 36 (60) | 31 (74) | 5 (28) | 0.21 |
| Overweight/obese, n (%) | 24 (40) | 11 (26) | 13 (72) | 0.002 |
| WC, mean ± SD | 67.0 ± 13.0 | 67.0 ± 13.0 | 13.0 ± 8.4 | 0.001 |
| WHtR, mean ± SD | 0.5 ± 0.1 | 0.5 ± 0.1 | 0.6 ± 0.1 | 0.001 |
| Central obesity (WHtR ≥ 0.5), n (%) | 32 (53) | 16 (38) | 16 (89) | 0.001 |
|
PASI, mean ± SD Median ± IQR |
4.3 ± 4.0 3.1 ± 3.0 |
4.3 ± 4.0 3.0 ± 3.0 |
4.0 ± 3.5 3.6 ± 3.6 |
0.54 |
| Mild psoriasis, n (%) | 42 (70) | 29 (69) | 13 (72) | 0.14 |
| Moderate-to-severe psoriasis, n (%) | 18 (30) | 13 (31) | 5 (28) | 0.21 |
| Familial history of psoriasis, n (%) | 34 (57) | 24 (57) | 10 (56) | 0.44 |
| Familial history of HPT and/or DM and/or HCT, n (%) | 40 (67) | 18 (45) | 22 (55) | 0.44 |